T-group (topology)
4954.1.1 central helical domain in RNA-polymerase beta-prime subunit
Ligands and drugs
2,167
Member domains
582
with ligand contacts (≤ 4 Å)
26.9% of members
401
with DrugDomain annotations
18.5% of members
44
with a DrugBank compound
2.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 4954.1.1 belongs to X-group 4954 central helical domain in RNA-polymerase beta-prime subunit, which binds 6.7 ligand superclasses per 20 proteins, narrower than 66% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02596 | APC | alpha,beta-Methyleneadenosine 5'-triphosphate | 8 |
| DB02431 | CTP | Cytidine-5'-Triphosphate | 5 |
| DB04785 | STD | Streptolydigin | 5 |
| DB00171 | ATP | ATP | 4 |
| DB03532 | G2P | Phosphomethylphosphonic acid guanylate ester | 4 |
| DB04005 | UTP | Uridine 5'-triphosphate | 4 |
| DB04137 | GTP | Guanosine-5'-Triphosphate | 4 |
| DB00142 | GLU | Glutamic acid | 2 |
| DB04022 | G4P | Guanosine tetraphosphate | 2 |
| DB08226 | MXP | Myxopyronin B | 2 |
| DB08266 | NE6 | Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 540 |
| MGmetal | MAGNESIUM ION | 18 |
| 1N7 | CHAPSO | 9 |
| APC | DIPHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER | 6 |
| G2P | PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER | 6 |
| 2TM | 5'-O-[(S)-hydroxy{[(S)-hydroxy(phosphonooxy)phosphoryl]methyl}phosphoryl]cytidine | 5 |
| 4QM | (3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-pentan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol | 4 |
| 5N0 | 3-({3-[(3-{[4-({4-[(4-{[4-({(2R)-2-amino-4-[(1-methyl-4-{[1-methyl-4-({1-methyl-4-[(1-methyl-1H-imidazole-2-carbonyl)amino]-1H-imidazole-2-carbonyl}amino)-1H-pyrrole-2-carbonyl]amino}-1H-pyrrole-2-carbonyl)amino]butanoyl}amino)-1-methyl-1H-imidazole-2-carbonyl]amino}-1-methyl-1H-pyrrole-2-carbonyl)amino]-1-methyl-1H-pyrrole-2-carbonyl}amino)-1-methyl-1H-pyrrole-2-carbonyl]amino}propyl)(methyl)amino]propyl}carbamoyl)benzoic acid | 4 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 4 |
| CTP | CYTIDINE-5'-TRIPHOSPHATE | 4 |
| STD | STREPTOLYDIGIN | 4 |
| UTP | URIDINE 5'-TRIPHOSPHATE | 4 |
| G4P | GUANOSINE-5',3'-TETRAPHOSPHATE | 3 |
| NE6 | methyl [(1E,5R)-5-{(3S)-3-[(2E,4E)-2,5-dimethylocta-2,4-dienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate | 3 |
| 4C2 | N-[3,4-dioxo-2-(4-{[4-(trifluoromethyl)benzyl]amino}piperidin-1-yl)cyclobut-1-en-1-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide | 2 |
| 4C6 | 3,5-dimethyl-N-{2-[4-(4-methylbenzyl)piperidin-1-yl]-3,4-dioxocyclobut-1-en-1-yl}-1,2-oxazole-4-sulfonamide | 2 |
| GLU | GLUTAMIC ACID | 2 |
| GTP | GUANOSINE-5'-TRIPHOSPHATE | 2 |
| MXP | Myxopyronin B | 2 |
| PBmetal | LEAD (II) ION | 2 |